Correlation Between Medicofarma Biotech and ING Bank

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and ING Bank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and ING Bank into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and ING Bank lski, you can compare the effects of market volatilities on Medicofarma Biotech and ING Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of ING Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and ING Bank.

Diversification Opportunities for Medicofarma Biotech and ING Bank

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Medicofarma and ING is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and ING Bank lski in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ING Bank lski and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with ING Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ING Bank lski has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and ING Bank go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and ING Bank

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the ING Bank. In addition to that, Medicofarma Biotech is 2.73 times more volatile than ING Bank lski. It trades about -0.2 of its total potential returns per unit of risk. ING Bank lski is currently generating about -0.24 per unit of volatility. If you would invest  25,100  in ING Bank lski on August 30, 2024 and sell it today you would lose (2,400) from holding ING Bank lski or give up 9.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Medicofarma Biotech SA  vs.  ING Bank lski

 Performance 
       Timeline  
Medicofarma Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
ING Bank lski 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ING Bank lski has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Medicofarma Biotech and ING Bank Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicofarma Biotech and ING Bank

The main advantage of trading using opposite Medicofarma Biotech and ING Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, ING Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ING Bank will offset losses from the drop in ING Bank's long position.
The idea behind Medicofarma Biotech SA and ING Bank lski pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance